References
- Shah JP, Lydiatt W. Treatment of cancer of the head and neck. CA Cancer J Clin 1995; 45: 352–68
- Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57–70
- Cohen GM. Caspases: the executioners of apoptosis. Biochem J 1997; 326: 1–16
- Guicciardi ME, Leist M, Gores GJ. Lysosomes in cell death. Oncogene 2004; 23: 2881–90
- Rochefort H, Liaudet-Coopman E. Cathepsin D in cancer metastasis: a protease and a ligand. APMIS 1999; 107: 86–95
- Roshy S, Sloane BF, Moin K. Pericellular cathepsin B and malignant progression. Cancer Metastasis Rev 2003; 22: 271–86
- Zeillinger R, Swoboda H, Machacek E, Nekahm D, Sliutz G, Knogler W, et al. Expression of cathepsin D in head and neck cancer. Eur J Cancer 1992; 28A: 1413–5
- Kos J, Smid A, Krasovec M, Svetic B, Lenarcic B, Vrhovec I, et al. Lysosomal proteases cathepsins D, B, H, L and their inhibitors stefins A and B in head and neck cancer. Biol Chem Hoppe Seyler 1995; 376: 401–5
- Kawasaki G, Kato Y, Mizuno A. Cathepsin expression in oral squamous cell carcinoma: relationship with clinicopathologic factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 93: 446–54
- Vigneswaran N, Zhao W, Dassanayake A, Muller S, Miller DM, Zacharias W. Variable expression of cathepsin B and D correlates with highly invasive and metastatic phenotype of oral cancer. Hum Pathol 2000; 31: 931–7
- Berchem G, Glondu M, Gleizes M, Brouillet J-P, Vignon F, Garcia M, et al. Cathepsin-D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis. Oncogene 2002; 21: 5951–5
- Öllinger K, Brunmark A. Effect of hydroxy substituent position on 1,4-naphthoquinone toxicity to rat hepatocytes. J Biol Chem 1991; 266: 21496–503
- Roberg K, Öllinger K. Oxidative stress causes relocation of the lysosomal enzyme cathepsin D with ensuing apoptosis in neonatal rat cardiomyocytes. Am J Pathol 1998; 152: 1151–6
- Johansson A-C, Steen H, Öllinger K, Roberg K. Cathepsin D mediates cytochrome c release and caspase activation in human fibroblast apoptosis induced by staurosporine. Cell Death Differ 2003; 10: 1253–9
- Roberg K, Johansson U, Öllinger K. Lysosomal release of cathepsin D precedes relocation of cytochrome c and loss of mitochondrial transmembrane potential during apoptosis induced by oxidative stress. Free Radic Biol Med 1999; 27: 1228–37
- Öllinger K. Inhibition of cathepsin D prevents free-radical-induced apoptosis in rat cardiomyocytes. Arch Biochem Biophys 2000; 373: 346–51
- Björnberg F, Lantz M, Gullberg U. Metalloproteases and serineproteases are involved in the cleavage of the two tumour necrosis factor (TNF) receptors to soluble forms in the myeloid cell lines U-937 and THP-1. Scand J Immunol 1995; 42: 418–24
- Dubowchik GM, Gawlak SL, Firestone RA. The in vitro effects of three lysosomotropic detergents against three human tumor cell lines. Bioorg Med Chem Lett 1995; 5: 893–8
- Li W, Yuan XM, Nordgren G, Dalen H, Dubowchik GM, Firestone RA, et al. Induction of cell death by the lysosomotropic detergent MSDH. FEBS Lett 2000; 470: 35–9
- Vancompernolle K, Van Herreweghe F, Pynaert G, Van de Craen M, De Vos K, Totty N, et al. Atractyloside-induced release of cathepsin B, a protease with caspase-processing activity. FEBS Lett 1998; 438: 150–8
- Katunuma N, Matsui A, Le QT, Utsumi K, Salvesen G, Ohashi A. Novel procaspase-3 activating cascade mediated by lysoapoptases and its biological significance in apoptosis. Adv Enzyme Regul 2001; 41: 237–50
- Stoka V, Turk B, Schendel SL, Kim T-H, Cirman T, Snipas SJ, et al. Lysosomal protease pathway to apoptosis: cleavage of Bid, not pro-caspases, is the most likely route. J Biol Chem 2000; 276: 3149–57
- John A, Tuszynski G. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res 2001; 7: 14–23
- Dabrosin C, Johansson A-C, Öllinger K. Decreased secretion of cathepsin D in breast cancer in vivo by tamoxifen: mediated by the mannose-6-phosphate/IGF-II receptor?. Breast Cancer Res Treat 2004; 85: 229–38
- Aderka D. The potential biological and clinical significance of the soluble tumor necrosis factor receptors. Cytokine Growth Factor Rev 1996; 7: 231–40